Imunon terminates interim CFO Gaiero, appoints Kimberly Graper as interim CFO effective June 13

Imunon, Inc.

Terminated consulting agreement with Monomoy Advisors and David Gaiero as interim CFO, effective June 13, 2025.
Kimberly Graper appointed interim CFO, also serving as principal financial and accounting officer.
Graper has been VP of Finance and Corporate Controller at Imunon since October 2022.
Her annual salary is $244,800 with a target bonus of 30% of base salary.
Graper holds a BS in Accounting from Clemson and a JD from Seton Hall; CPA licensed in New Jersey.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

David Gaiero

interim Chief Financial Officer

IMNN · Imunon, Inc.

Effective: 2025-06-13
Successor: Kimberly Graper
Filed: June 13, 2025, 7:59 PM ET

On June 13, 2025, Imunon, Inc. (the “Company”) terminated the consulting agreement (as amended, the “Agreement”), dated April 15, 2024, by and between the Company and Monomoy Advisors, LLC, a financial advisory services firm (“Monomoy”), as well as David Gaiero’s service pursuant to the Agreement as the Company’s interim Chief Financial Officer (a position he has held since June of 2024), in each case effective June 13, 2025.

Appointed (interim)

Kimberly Graper

interim Chief Financial Officer

IMNN · Imunon, Inc.

Effective: 2025-06-13
Filed: June 13, 2025, 7:59 PM ET

As a result of the termination of the Agreement and Mr. Gaiero’s related service, effective June 13, 2025, the Company appointed Kimberly Graper to serve as the Company’s interim Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Gaiero was terminated as interim Chief Financial Officer at Imunon, Inc..

Action: terminated
Role: interim Chief Financial Officer

Exact text from the filing

On June 13, 2025, Imunon, Inc. (the “Company”) terminated the consulting agreement (as amended, the “Agreement”), dated April 15, 2024, by and between the Company and Monomoy Advisors, LLC, a financial advisory services firm (“Monomoy”), as well as David Gaiero’s service pursuant to the Agreement as the Company’s interim Chief Financial Officer (a position he has held since June of 2024), in each case effective June 13, 2025.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Kimberly Graper was appointed as interim Chief Financial Officer at Imunon, Inc..

Action: appointed
Role: interim Chief Financial Officer

Exact text from the filing

As a result of the termination of the Agreement and Mr. Gaiero’s related service, effective June 13, 2025, the Company appointed Kimberly Graper to serve as the Company’s interim Chief Financial Officer.

View on SEC.gov

Imunon, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-015124

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.